摘要
Previously, we demonstrated that magnolol isolated from the bark of Magnolia officinalis has anticancer activity in colon, hepatoma, and leukemia cell lines. In this study, we show that magnolol concentration dependently (0-40 μM) decreased the cell number in a cultured human glioblastoma cancer cell line (U373) and arrested the cells at the G0/G1 phase of the cell cycle. Magnolol treatment decreased the protein levels of cyclins A and D1 and increased p21/Cip1, but not cyclins B and D3, cyclin-dependent kinase (CDK)2, CDK4, CDC25C, Weel, p27/Kip1, and p53. The CDK2p21/Cip1 complex was increased, and the CDK2 kinase activity was decreased in the magnololtreated U373. Pretreatment of U373 with p21/Cip1 specific antisense oligodeoxynucleotide prevented the magnolol-induced increase of p21/Cip1 protein levels and the decrease of DNA synthesis. Magnolol at a concentration of 100μM induced DNA fragmentation in U373. Our findings suggest the potential applications of magnolol in the treatment of human brain cancers.
原文 | 英語 |
---|---|
頁(從 - 到) | 7331-7337 |
頁數 | 7 |
期刊 | Journal of Agricultural and Food Chemistry |
卷 | 57 |
發行號 | 16 |
DOIs | |
出版狀態 | 已發佈 - 2009 |
ASJC Scopus subject areas
- 農業與生物科學 (全部)
- 化學 (全部)